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Abstract
Background
Trichiasis is present when one or more eyelashes touches the eye. Uncorrected, it can
cause blindness. Accurate estimates of numbers affected, and their geographical distribu-
tion, help guide resource allocation.
Methods
We obtained district-level trichiasis prevalence estimates in adults for 44 endemic and previ-
ously-endemic countries. We used (1) the most recent data for a district, if more than one
estimate was available; (2) age- and sex-standardized corrections of historic estimates,
where raw data were available; (3) historic estimates adjusted using a mean adjustment fac-
tor for districts where raw data were unavailable; and (4) expert assessment of available
data for districts for which no prevalence estimates were available.
Findings
Internally age- and sex-standardized data represented 1,355 districts and contributed 662
thousand cases (95% confidence interval [CI] 324 thousand–1.1 million) to the global total.
Age- and sex-standardized district-level prevalence estimates differed from raw estimates
by a mean factor of 0.45 (range 0.03–2.28). Previously non- stratified estimates for 398 dis-
tricts, adjusted by ×0.45, contributed a further 411 thousand cases (95% CI 283–557 thou-
sand). Eight countries retained previous estimates, contributing 848 thousand cases (95%
CI 225 thousand-1.7 million). New expert assessments in 14 countries contributed 862 thou-
sand cases (95% CI 228 thousand–1.7 million). The global trichiasis burden in 2016 was 2.8
million cases (95% CI 1.1–5.2 million).
Interpretation
The 2016 estimate is lower than previous estimates, probably due to more and better data;
scale-up of trichiasis management services; and reductions in incidence due to lower active
trachoma prevalence.
Author summary
As an individual with trichiasis blinks, the eyelashes abrade the cornea, which can lead to
corneal opacity and blindness. Through high quality surgery, which involves altering the
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position of the eyelid margin, it is possible to reduce the number of people with trichiasis.
Accurate estimates of the number of persons with trichiasis and their geographical distri-
bution are needed in order to effectively align resources for surgery and other necessary
services. We obtained district-level trichiasis prevalence estimates for 44 endemic and pre-
viously-endemic countries. We used the most recently available data and expert assess-
ments to estimate the global burden of trichiasis. We estimated that in 2016 the global
burden was 2.8 million cases (95% CI 1.1–5.2 million).
The 2016 estimate is lower than previous estimates, probably due to more and better
data; scale-up of trichiasis management services; and reductions in incidence due to lower
active trachoma prevalence.
Introduction
Trachoma, a neglected tropical disease, is endemic or has recently been endemic in more than
50 countries[1]. It affects the most impoverished people of the world. Improved living stan-
dards are credited for the disappearance of trachoma from Europe and North America, but in
many less developed countries, trachoma is still a public health problem, and contributes to
the continued suffering and deepening of poverty of millions of people.
Chlamydia trachomatis is the causative organism. Repeated ocular chlamydial infection
results in chronic inflammation, characterised by sub-epithelial follicles in the tarsal conjunc-
tiva, which may be sufficiently large and numerous to meet the definition of trachomatous
inflammation—follicular (TF), a key sign for assessing trachoma prevalence[2]. Over time,
with repeated reinfection, scarring may develop; this scarring can eventually cause the eyelid
to turn inwards in some people, resulting in eyelashes touching the globe. This is called tracho-
matous trichiasis (TT) and is very painful[3]. As an individual with trichiasis blinks, the eye-
lashes abrade the cornea, which can lead to corneal opacity and blindness[4].
The World Health Organization (WHO) endorses population based prevalence surveys
(PBPSs) to guide decisions regarding implementation of interventions for trachoma elimina-
tion[5]. The typical survey design involves two-stage cluster sampling, which uses probability-
proportional-to-size methodologies to select 20–30 clusters. The outputs are estimates of the
prevalence of TF in children aged 1–9 years, and the prevalence of TT in adults aged 15 years
and older[6].
Through high quality surgery, which involves altering the position of the eyelid margin,[7]
it is possible to reduce the number of people with TT. Accurate estimates of the number of per-
sons with TT (the TT backlog) and their geographical distribution are needed in order to effec-
tively align resources for surgery and other necessary services.
In 2009, Mariotti et al estimated the global TT backlog to be 8.2 million people[8]. This esti-
mate was derived by summarizing a combination of published and unpublished information.
First, a literature review was performed to identify published prevalence data. Where pub-
lished data were not available, unpublished data were compiled from the Eleventh (2007)
Meeting of the WHO Alliance for the Global Elimination of Trachoma by 2020[9]. Where
information was still missing, unpublished reports were provided by health ministries. Finally,
if none of these resources were available, data were extrapolated from a proxy country believed
to have common epidemiological conditions and demographic structure.
There are many uncertainties inherent in the 2009 estimate[8]. First, where PBPS data were
available, the results were not systematically stratified by age and sex. This is problematic
because women and the elderly are more likely than men and younger adults, respectively, to
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(1) be at home at the time that a house-to-house survey team calls, and (2) have TT. Second, in
countries for which data were available, survey coverage was generally far from complete.
Though not an invariable rule, surveys to estimate the prevalence of neglected diseases have a
tendency to be done first in areas of high prevalence; for the 2009 estimate, if any data were
available for a particular country, the TT prevalence figure from those data was applied across
the yet-to-be-mapped suspected-endemic population. Third, the use of proxy countries is
extremely subjective.
In 2012, WHO collected and collated provisional 2011 country reports, and published an
updated figure for the global TT backlog. The total given was 7.3 million people, but the meth-
odologies used in each country to generate national backlog figures were not described[10];
they are likely to have been highly heterogeneous.
From December 2012 to January 2016, the Global Trachoma Mapping Project (GTMP)
sought to systematically complete the global trachoma map using standardized techniques for
both collecting and analysing survey data[11]. Eligibility[12] and protocols [11]for mapping
were determined by expert working groups. GTMP measured trachoma prevalence using gold
standard PBPSs conducted at district level. People of all ages living in selected households of
1,546 districts across 29 countries were examined for trachoma, resulting in the examination
of 2.6 million people[13]. GTMP analyses included stratifying trichiasis prevalence estimates
against national population pyramids in an attempt to partially account for demographic dif-
ferences between those examined and the national averages.
As a result of the GTMP, there are now high quality PBPS data available for most sus-
pected-endemic areas that were previously unsurveyed. The availability of these data has cata-
lysed the current attempt to generate a new estimate of the global trichiasis backlog.
Methods
We updated previous global estimates using the best available data, according to the following
hierarchy, with all areas worldwide that have trichiasis prevalence estimates eligible for inclu-
sion. First, where GTMP data[11] were available, we used the age- and sex- stratified survey-
level trichiasis prevalence estimates for adults. In August 2014, GTMP added examination for
the presence or absence of trachomatous scarring (TS)[2] for all eyes determined to have tri-
chiasis; prior to this, and for all non-GTMP data, trichiasis prevalence estimates included tri-
chiasis with and without TS. All analyses of trichiasis were undertaken among adults aged 15
years and older only.
Second, where PBPSs had been done without the support of the GTMP, we requested de-
identified individual-level raw survey data from national health ministries, or appropriate gov-
ernment-designated agencies. Where those data were provided by 1 March 2016, we applied
the same age- and sex- stratification as was used in the GTMP[11].
Third, where PBPSs had been done but raw data were not available, survey-level prevalence
estimates (whether stratified by age and sex or not) were obtained from country programs.
When data had not been stratified, estimates were multiplied by the mean adjustment factor
for districts in which age- and sex- stratification was possible.
Fourth, if prevalence estimates were not available, we reviewed previous estimates through
desk reviews and communications with country programs. If there was adequate evidence to
revise the estimates, new estimates were used; otherwise, the 2009 estimates[8] were retained.
The population data used in these analyses were derived from the UN population division
(UNdata)[14] and www.worldpop.org[15]. As trachoma is a disease primarily affecting rural
populations[4], we used rural population estimates for this purpose. Rural population pyra-
mids were obtained from UNdata. Microsoft Excel (2007) was used to organize the datasets
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into 5-year age bands stratified by sex for each country. The percentage of the population
within each stratum was estimated from the bands. The district level populations were derived
from www.worldpop.org raster files[15] using the zonal statistics tool in ArcGIS 10.3[16]. The
raster files used here are a matrix of geolocated pixels where each pixel contains population
values. The sum values of the pixels falling within each district boundary was taken as the dis-
trict value. A sensitivity analysis was also performed, comparing the www.worldpop.org popu-
lation estimates to district population estimates provided by national trachoma elimination
programs. The mean ratio between the national program estimates and www.worldpop.org
was 0�97. Because of this close correlation, and for the purposes of standardizing our methods,
the www.worldpop.org data were used throughout this analysis.
For population-based prevalence surveys done without GTMP support but for which raw
data were available, the statistical software package R[17] was used to perform age- and sex-
post-stratification. First, the crude prevalence was calculated for each cluster. Second, the prev-
alence was stratified for each cluster by weighting the proportion of each sex-specific five-year
age band observed to have trichiasis by the proportion of the adults aged 15 years and older
expected to have that age and sex in that district, if available, or (if not available), nation-wide.
Third, the un-weighted arithmetic mean of the stratified cluster-level trichiasis proportions
was taken as the district-level prevalence. Sampling weights were not needed here as the sur-
veys used probability-proportional-to-size sampling and are therefore self-weighted. Once the
initial post-stratification was completed, bootstrapping was undertaken on the dataset for each
individual district to derive 95% confidence intervals (CIs). For a district surveyed by examin-
ing individuals in n clusters, this involved bootstrap resampling (with replacement) of n clus-
ters, over 10,000 replications. The R code is provided in the Appendix.
Where PBPSs had been done but raw data were not available, CIs were constructed around
the original estimate by applying an approximation to the binomial distribution
CI ¼ p   ðzˊ �s:e:Þto pþ ðzˊ �s:e:Þ, where p is the proportion of positive cases in the sample, s.
e. is
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
pð1   pÞ=n
p
, and zˊ is the standard normal distribution (95% CI = 1.96). Where the sam-
ple size was not available, a sample of 1000 was assumed. This method was used at the district-
level when data were available and country-level when previous estimates were retained.
When the district-level prevalence estimate was multiplied by the mean adjustment factor for
districts in which age- and sex- stratification was possible, the upper and lower bounds of the
corresponding confidence intervals were adjusted in the same way.
Post-stratified prevalence estimates and the lower and upper 95% CI bounds were multi-
plied by the 15-years-and-older population for the relevant district (projected to 2016) to pro-
vide an estimate of the number of persons with trichiasis.
Health ministries of endemic countries reviewed the output; for three countries, as will be
noted in the results section, the estimate was subsequently reduced to account for implementa-
tion of trichiasis surgery programs since the time of survey. This changed the category of esti-
mates in the countries involved from estimates based on PBPS data to “expert assessments”.
For expert backlog assessments, confidence intervals were constructed using the relative
precisions of all datasets for which bootstrapped CIs could be determined. The range of rela-
tive upper bound and lower bound precisions were trimmed to exclude 10% of the greatest
and least values. The means of the remainder were applied.
Upper (and lower) CI bounds around district-level estimates, regardless of the method used
for calculation, were summed to generate country-level, region-level and global estimates of
the upper (and lower) CI bounds.
A sensitivity analysis was performed where communications with country programs esti-
mated a value of zero. This involved selecting proxy countries based on similar geography and
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hygiene and sanitation situations and calculating the ratio of estimated country backlog over
country population. This ratio was then applied to the zero value countries to estimate a back-
log. Hygiene and sanitation data were derived from the WHO/UNICEF Joint Monitoring Pro-
gram for Water Supply, Sanitation and Hygiene (JMP) [18].
The study was approved by the Research Ethics Committee of the London School of
Hygiene & Tropical Medicine (11208). The corresponding author had full access to all the data
and had final responsibility for the decision to submit for publication.
Results
The 2009 estimate included 57 historically trachoma-endemic countries; this updated estimate
reviewed 65 known and suspected trachoma-endemic countries. Descriptive statistics for clus-
ter level data are found in the individual country-level publications. Data from 1,355 districts
in 31 countries were age- and sex- stratified and contribute an estimated 662 thousand cases
(95% confidence interval (CI) 324 thousand-1.1 million) to the global total. These data were
made up of 29,847 clusters, averaging 22 clusters per district. Adjusting prevalence estimates
by age and sex reduced raw district-level estimates by a mean factor of 0.45 (range 0.03–2.28;
Fig 1). This value was calculated by averaging the ratio of adjusted and unadjusted prevalence
estimates across districts that had raw data available. While the district-level estimates reduce
by a mean factor of 0.45, the overall country-level backlog reduced by a mean factor of 0.56
(range 0.22–0.94) (Table 1).
Fig 1. Histogram for ratio of adjusted and unadjusted prevalence estimates.
https://doi.org/10.1371/journal.pntd.0007835.g001
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Table 1. Estimated national-level trichiasis backlogs, 2016, with comparisons to the corresponding estimates for 2009.
WHO region Country 2009
estimate[8]
(data generally
from 2007)
Source for 2016 estimate
(1)
2016
estimate [year of data
collection] (2)
(95% confidence
intervals)
Representativeness
African Region Algeria 86,700 Retained previous estimate 86,700
(23,022–175,625)
Angola no data Expert assessment (3) 0
Benin 7,600 GTMP[20] 11,782 [2014–2015]
(5,148–20,861)
Estimate based on 12 age- and sex-adjusted PBPS
datasets covering all districts in the country where
evidence indicates trachoma may be a public health
problem
Botswana 32,900 Expert assessment (3) 0
Burkina Faso 32,800 PBPS–no raw data
available
19,443 [2005–2015]
(5,381–35,236)
Estimate based on 63 PBPS datasets covering all
districts in the country
Burundi no data Expert assessment (3) 0
Cameroon 47,200 PBPS–no raw data
available
698 [2012–2014]
(27–1,523)
Estimate based on 1) 35 age- and sex-adjusted PBPS
datasets, plus 2) 15 PBPS datasets, covering all
districts in the country where evidence indicates
trachoma may be a public health problem
PBPS–raw data available 10,743 [2010–2014]
(5,705–16,525)
Central African
Republic
1,000 PBPS–no raw data
available
6,539 [2011]
(1,991–11,259)
Estimate based on 8 PBPS datasets; security
concerns prevented the remaining 7 districts in the
country where evidence indicates trachoma may be
a public health problem from being surveyed
Chad 34,300 GTMP 24,597 [2014–2015]
(8,513–44,924)
Estimate based on 1) 43 age- and sex-adjusted PBPS
datasets, plus 2) 14 PBPS datasets. At the time of
publication 1 district where evidence indicates
trachoma may be a public health problem remained
to be surveyed
PBPS–no raw data
available
23,024 [2002]
(15,365–30,683)
Congo GTMP 0 [2015] Estimate based on 1 age- and sex-adjusted PBPS
dataset covering all districts in the country where
evidence indicated that trachoma might have been a
public health problem
Coˆte d’Ivoire 59,900 GTMP 1, 216 [2015]
(176–2,582)
Estimate based on 10 age- and sex-adjusted PBPS
datasets covering all districts in the country where
evidence indicates trachoma may be a public health
problem
Democratic
Republic of the
Congo
no data GTMP[21] 33,333 [2014–2016]
(18,369–52,870)
Estimate based on 30 age- and sex-adjusted PBPS
datasets; security concerns prevented 1 district from
being surveyed. At the time of publication an
additional 9 districts where evidence indicates
trachoma may be a public health problem remained
to be surveyed.
Eritrea 42,000 GTMP 774 [2014]
(274–1,308)
Estimate based on 1) 2 age- and sex-adjusted PBPS
datasets, plus 2) 36 PBPS datasets; security concerns
prevented the remaining 1 district in the country
where evidence indicates trachoma may be a public
health problem from being surveyed
PBPS–no raw data
available
24,793 [2006–2014]
(15,005–34,823)
Ethiopia 1,272,600 Expert assessment[22–26]
(4)
693,037 [2012–2016]
(184,025–1,403,858)
Expert assessment based on 1) a backlog calculated
from 196 age- and sex-adjusted PBPS datasets;
security concerns prevented the remaining 16
districts in the country where evidence indicates
trachoma may be a public health problem from
being surveyed; minus 2) programmatic TT surgery
output from 2012–2016
Gambia 10,500 PBPS–no raw data
available
0 [2016] PBPS datasets covering all districts in the country
where evidence indicates trachoma may be a public
health problem
(Continued)
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Table 1. (Continued)
WHO region Country 2009
estimate[8]
(data generally
from 2007)
Source for 2016 estimate
(1)
2016
estimate [year of data
collection] (2)
(95% confidence
intervals)
Representativeness
Ghana 3,000 PBPS–no raw data
available
1,379 [2007–2008]
(188–2,875)
Estimate based on 23 PBPS datasets, covering all
districts in the country where evidence indicated
that trachoma may have been a public health
problem
Guinea 25,100 GTMP 5,523 [2014–2016]
(1,141–11,834)
Estimate based on 31 age- and sex-adjusted PBPS
datasets, covering all districts in the country where
evidence indicates trachoma may be a public health
problem
PBPS–raw data available 24,302 [2011–2013]
(13,035–38,193)
Guinea-Bissau 16,400 PBPS–raw data available 21,255 [2005]
(12,975–29,638)
Estimate based on 11 PBPS datasets, covering all
districts in the country where evidence indicates
trachoma may be a public health problem
Kenya 306,800 PBPS–no raw data
available
30,195 [2004–2012]
(21,404–39,116)
Estimate based on 1) 3 age- and sex-adjusted PBPS
datasets, plus 2) 12 PBPS datasets, covering all
districts in the country where evidence indicates
trachoma may be a public health problem
PBPS–raw data available 21,363 [2004]
(13,583–31,471)
Malawi 33,400 GTMP[27, 28] 13,446 [2013–2015]
(3,302–27,937)
Estimate based on 1) 30 age- and sex-adjusted PBPS
datasets, plus 2) 3 PBPS datasets, covering all
districts in the country where evidence indicates
trachoma may be a public health problem
PBPS–no raw data
available
1,128 [2012]
(227–2,124)
PBPS–raw data available 817 [2014]
(48–1,918)
Mali 67,600 Expert assessment (5) 13,852
(3,678–28,059)
Estimate based on 1) 55 PBPS datasets, covering all
districts in the country minus 2) programmatic TT
surgery output between survey completion and 2016
Mauritania 2,500 PBPS–no raw data
available
1,556 [2004–2013]
(250–3,325)
Estimate based on 29 PBPS datasets, covering all
districts in the country where evidence indicates
trachoma may be a public health problem
Mozambique 60,500 GTMP[29] 18,817 [2013–2014]
(3,958–39,883)
Estimate based on 1) 99 age- and sex-adjusted PBPS
datasets, covering all districts in the country where
evidence indicates trachoma may be a public health
problem
PBPS–raw data available 96 [2015]
(89–111)
Namibia 6,100 Expert assessment (3) 0
Niger 59,600 Expert assessment (8) 40,592
(9,712–83,784)
Estimate based on 1) 49 PBPS datasets, covering all
districts in the country where evidence indicates
trachoma may be a public health problem minus 2)
programmatic TT surgery output between survey
completion and 2016
Nigeria 627,300 GTMP[30–34] 193,951 [2013–2014]
(111,251–297,277)
Estimate based on 1) 294 age- and sex-adjusted
PBPS datasets, plus 2) 103 PBPS datasets, security
concerns prevented the remaining 47 districts in the
country where evidence indicates trachoma may be
a public health problem from being surveyed
PBPS–no raw data
available
90,865 [2003–2014]
(56,635–126,704)
PBPS–raw data available 3,800 [2014–2015]
(1,801–6,295)
Senegal 129,800 GTMP 12,707 [2014]
(6,823–19,364)
Estimate based on 1) 20 age- and sex-adjusted PBPS
datasets, plus 2) 27 PBPS datasets, covering all
districts in the country where evidence indicates
trachoma may be a public health problem
PBPS–no raw data
available
30,905 [2000–2012]
(18,450–43,437)
PBPS–raw data available 3,077 [2015]
(1,502–4,695)
(Continued)
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Table 1. (Continued)
WHO region Country 2009
estimate[8]
(data generally
from 2007)
Source for 2016 estimate
(1)
2016
estimate [year of data
collection] (2)
(95% confidence
intervals)
Representativeness
South Sudan no data Expert assessment 81,093
(21,533–164,267)
Estimate provided by the Ministry of Health, South
Sudan. To date, only a quarter of South Sudan has
been mapped–this figure is likely to be an under-
estimate for the country
Togo 2,900 PBPS–no raw data
available
318 [2009]
(45–680)
Estimate based on 3 PBPS datasets covering all
districts in the country where evidence indicates
trachoma may be a public health problem
Uganda 610,600 GTMP 680 [2014]
(253–1,200)
Estimate based on 1) 39 age- and sex-adjusted PBPS
datasets, plus 2) 5 PBPS datasets covering all districts
in the country where evidence indicates trachoma
may be a public health problem
PBPS–no raw data
available
14,559 [2008–2012]
(9,635–19,483)
PBPS–raw data available 65,329 [2013–2016]
(39,924–149,042)
United Republic
of Tanzania
214,800 GTMP[35, 36] 8,096 [2014]
(2,491–15,225)
Estimate based on 97 age- and sex-adjusted PBPS
datasets, covering all districts in the country where
evidence indicates trachoma may be a public health
problem
PBPS–raw data available 63,157 [2004–2016]
(28,844–87,028)
Zambia 8,500 GTMP 1,524 [2015]
(712–2,670)
Estimate based on 1) 7 age- and sex- adjusted PBPS
datasets, plus 2) 3 PBPS datasets covering all districts
in the country where evidence indicates trachoma
may be a public health problem
PBPS–no raw data
available
2,168 [2010–2015]
(1,289–3,047)
Zimbabwe 44,100 GTMP 6,765 [2014–2015]
(3,133–10,988)
Estimate based on 16 age- and sex-adjusted PBPS
datasets covering all districts in the country where
evidence indicates trachoma may be a public health
problem
Eastern
Mediterranean
Region
Afghanistan 83,100 Retained previous estimate 83,100
(22,066–168,332)
Djibouti 3,900 Expert assessment (6) 75
(20–152)
Egypt 35,400 GTMP 35,362 [2015]
(16,003–58,414)
Estimate based on 1) 4 age- and sex-adjusted PBPS
datasets, plus 2) 1 PBPS dataset
PBPS–no raw data
available
35,400 [2015]
(30,596–40,204)
Iran (Islamic
Republic of)
49,300 Expert assessment (3) 0
Iraq 43,900 Expert assessment (3) 0
Libya 13,200 Expert assessment (7) 33,400
(8,869–67,657)
Morocco 6,400 PBPS–no raw data
available
0 [2015] Estimate based on PBPS datasets covering all
districts in the country where evidence indicated
that trachoma may have been a public health
problem
Oman 600 PBPS–no raw data
available
600 [2005]
(41–619)
Estimate based on PBPS datasets covering all
districts in the country where evidence indicated
that trachoma may have been a public health
problem
Pakistan 71,700 GTMP 5,330 [2015]
(1,160–10,732)
Estimate based on 1) 42 age- and sex-adjusted PBPS
datasets, plus 2) 31 PBPS datasets; security concerns
prevented 15 districts from being surveyed. At the
time of publication an additional 1 district where
evidence indicates trachoma may be a public health
problem remained to be surveyed.
PBPS–no raw data
available
23,420 [2012]
(12,205–34,975)
(Continued)
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Table 1. (Continued)
WHO region Country 2009
estimate[8]
(data generally
from 2007)
Source for 2016 estimate
(1)
2016
estimate [year of data
collection] (2)
(95% confidence
intervals)
Representativeness
Somalia 10,300 Retained previous estimate 10,300
(2,735–20,864)
Sudan 528,100 GTMP[37] 22,508 [2014–2015]
(14,208–33,449)
Estimate based on 1) 109 age- and sex-adjusted
PBPS datasets, plus 2) 22 PBPS datasets; security
concerns prevented 12 districts from being
surveyed. At the time of publication an additional 1
district where evidence indicates trachoma may be a
public health problem remained to be surveyed.
PBPS–no raw data
available
6,751 [2006–2013]
(2,599–10,903)
PBPS–raw data available 36,982 [2007–2010]
(7,070–80,470)
Yemen 270,800 GTMP 5,821 [2013–2015]
(896–13,165)
Estimate based on 1) 42 age- and sex-adjusted PBPS
datasets; security concerns prevented the remaining
38 districts in the country where evidence indicates
trachoma may be a public health problem from
being surveyed
Region of the
Americas
Brazil 58,000 Retained previous estimate 58,000 [2003–2006]
(15,401–117,488)
Estimate based on PBPS datasets covering all
districts in the country where evidence indicates
trachoma may be a public health problem
Colombia no data GTMP 48 [2015]
(0–123)
Estimate based on 1) 3 age- and sex-adjusted PBPS
datasets, plus 2) 6 PBPS datasets. At the time of
publication an additional 3 districts where evidence
indicates trachoma may be a public health problem
remained to be surveyed.
PBPS–no raw data
available
23 [2003–2009]
(4–44)
Guatemala 30 PBPS–no raw data
available
543 [2011]
(268–819)
Estimate based on 2 PBPS datasets covering all
districts in the country where evidence indicates
trachoma may be a public health problem
Mexico 20 Expert assessment (3) 0
South-East Asia
Region
India 443,000 Retained previous estimate 443,000
(117,632–897,368)
Nepal 138,800 PBPS–no raw data
available
25,240 [2001–2012]
(16,889–33,631)
Estimate based on 1) 30 age- and sex-adjusted PBPS
datasets, plus 2) 17 PBPS datasets covering all
districts in the country where evidence indicates
trachoma may be a public health problem
PBPS–raw data available 3,252 [2002–2009]
(462–7,323)
Western Pacific
Region
Australia 1,100 Retained previous estimate 1,100
(292,2,228)
Cambodia 29,200 GTMP[38] 4,999 [2014–2015]
(729–10,676)
Estimate based on 14 age- and sex-adjusted PBPS
datasets covering all districts in the country where
evidence indicates trachoma may be a public health
problem
China 2,330,600 PBPS–no raw data
available
71,280
(70,399–72,161)
Estimate based on PBPS datasets covering all
districts in the country where evidence indicated
that trachoma may have been a public health
problem before 2012
Fiji 800 PBPS using the methods of
the GTMP[39] and
subsequent investigation
[40]
0 [2013] Estimate based on 1 age- and sex-adjusted PBPS
dataset covering all districts in the country where
evidence indicates trachoma may be a public health
problem
Kiribati 100 GTMP 69 [2015]
(30–108)
Estimate based on 1 age- and sex-adjusted PBPS
dataset covering all districts in the country where
evidence indicates trachoma may be a public health
problem
Lao People’s
Democratic
Republic
900 GTMP[41] 630 [2013–2015]
(0–1,728)
Estimate based on 16 age- and sex-adjusted PBPS
datasets covering all districts in the country where
evidence indicates trachoma may be a public health
problem
(Continued)
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Estimates from PBPSs in 398 districts could not be stratified by age and sex because the
original datasets were unavailable; the unadjusted backlogs in these districts totalled 781 thou-
sand cases. We adjusted these estimates by multiplying them across the board by 0.45, yielding
411 thousand cases (95% CI 283–557 thousand).
Based on new expert assessment of available data, it was determined that eight countries no
longer have a trichiasis backlog. These countries were Angola, Botswana, Burundi, Iran, Iraq,
Namibia, Nauru, and Mexico. For six countries—Djibouti, Ethiopia, Libya, Mali, Niger and
South Sudan—local expert assessment generated revised, non-zero estimates. In Ethiopia,
Niger and Mali, the local expert assessment was undertaken at the request of the health minis-
try, where, for each district the number of surgeries done since the most recent prevalence sur-
vey (as reported annually to WHO) was subtracted from the estimated district-level backlog.
(Incorporating surgical delivery in these three countries reduced the global backlog estimate
by 124,433 cases: Ethiopia 69,133, Mali 32,083, and Niger 23,217.) For one country, other pub-
lished estimates[19] were used.
Finally, there were seven countries for which the 2009 estimates were retained. The coun-
try-level data derived from previous estimates and expert assessments contributes 61.4% of the
Table 1. (Continued)
WHO region Country 2009
estimate[8]
(data generally
from 2007)
Source for 2016 estimate
(1)
2016
estimate [year of data
collection] (2)
(95% confidence
intervals)
Representativeness
Myanmar 65,800 Retained previous estimate 65,800
(17,472–133,289)
Nauru 0 Expert assessment (3) 0
Papua New
Guinea
5,800 GTMP[42] 156 [2015]
(0–362)
Estimate based on 7 age- and sex-adjusted PBPS
datasets covering all districts in the country where
evidence indicates trachoma may be a public health
problem
Solomon Islands 500 GTMP[43] 44 [2013]
(4–104)
Estimate based on 1) 3 age- and sex-adjusted PBPS
datasets, plus 2) 5 PBPS datasets, covering all
districts in the country where evidence indicates
trachoma may be a public health problem
PBPS–no raw data
available
8 [2012]
(0–23)
Vanuatu 200 GTMP[44] 48 [2014]
(47–50)
Estimate based on 1 age- and sex-adjusted PBPS
datasets covering all districts in the country where
evidence indicates trachoma may be a public health
problem
Viet Nam 210,000 Expert assessment (6) 100,000[19]
(26,553–202,566)
1) Unless otherwise specified, “Retained previous estimate” refers to the 2009 estimate by Mariotti et al[8]
2) Individuals examined in these surveys were men and women aged�15 years
3) Health ministry reports that there is no evidence of trichiasis being a public health problem, or that evidence indicates that trichiasis is not a public health problem
4) Estimate provided by the Federal Ministry of Health of Ethiopia; determined by calculating the backlog indicated by the most recent population-based prevalence
survey in each trachoma-endemic district and subtracting from it the number of individuals with trichiasis managed by the health system since those surveys; 95% CIs
were calculated using the bootstrapping approach described in the methods and provided by the Ministry
5) Estimate provided by the Ministère de la Sante´, Mali; determined by calculating the backlog indicated by the most recent population-based prevalence survey in each
trachoma-endemic district and subtracting from it the number of individuals with trichiasis managed by the health system since those surveys; 95% CIs were calculated
using the bootstrapping approach described in the methods and provided by the Ministry
6) derived from information provided at the 2010 WHO Alliance for GET2020 meeting
7) Estimate informed by data from a Rapid Assessment of Avoidable Blindness (RAAB) survey
https://doi.org/10.1371/journal.pntd.0007835.t001
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overall estimate (Table 2 and Fig 2). Data included in the overall estimate had been collected
from 2000–2016 (Fig 3).
Through the inclusion of GTMP data, adjusting older datasets by age and sex, and obtain-
ing current local expert assessment of available data, the global backlog estimate reduces from
2009’s 8.2 million[8] (or 2012’s 7.3 million[10]) to 2.8 million (95% CI 1.1–5.2 million) in 2016
(Tables 2 and 3). The updated estimate reduced to zero cases in twelve countries, namely:
Angola, Botswana, Burundi, Congo, Fiji, Gambia, Iraq, Islamic Republic of Iran, Morocco,
Mexico, Namibia, and Nauru. (Updated survey data demonstrated zero prevalence in Congo,
Gambia, Morocco and Fiji, while health ministries in Angola, Botswana, Burundi, Iraq, Islamic
Republic of Iran, Mexico, Namibia and Nauru reported no current evidence of trichiasis.) The
sensitivity analysis performed for countries where the health ministry reported no current evi-
dence of trichiasis suggests these zero estimates may contribute to a global underestimate by a
margin of 13,285, a small difference in the context of the overall estimate, particularly given
uncertainty from other sources. The outputs from this analysis are provided in the Appendix.
In our estimates, data collected in surveys set up prior to August 2014 include all trichiasis,
irrespective of the presence or absence of trachomatous conjunctival scarring. Data collected
in surveys set up after August 2014 contributed data on trichiasis in eyes that also demon-
strated trachomatous conjunctival scarring (or had an eyelid that could not be everted, due to
presumed dense scar), thereby including only those cases of trichiasis attributable to trachoma.
In both scenarios the data represent both “managed” and “unmanaged” trichiasis, irrespective
of whether individuals have previously been offered corrective surgery or epilation[45].
Discussion
Trichiasis remains a significant public health problem in many countries, with a global backlog
estimated for 2016 at 2.8 million people, 61% of whom live in sub-Saharan Africa. While there
were methodological challenges in generating the 2009 estimate, it was the best estimate that
could be made with the information then available. The considerable reduction from that esti-
mate to the one generated here is likely to be the result of a combination of factors. First, there
are now more and better data derived from rigorous surveys. Second, in many countries, there
has been impressive programmatic scale up to manage TT, conducted by complex networks of
governments and their partners. Third, there is likely to be an effect on the incidence of TT
from the intensive efforts to reduce active trachoma prevalence in many contexts; such efforts
have been ramping up in endemic countries since the World Health Assembly’s 1998 commit-
ment to global elimination of trachoma[46]. Teasing out the relative contribution of each of
these factors is not possible at the present time, but regardless of cause, the reduction is wel-
come news for global health.
A better understanding of the backlog and distribution of trichiasis cases is necessary to
effectively plan for surgical services and other components of management of individuals with
trichiasis. To reduce TT prevalence in each district of each endemic country to<0.2% in
adults, which is the defined elimination threshold for TT[47], at least 2.0 million people will
Table 2. Backlog estimate attributed to each analysis methodology.
Method Geography Backlog estimate Percent of overall estimate
PBPS–raw data available 1,355 districts 662,403 23.8%
PBPS–no raw data available 398 districts 410,835 14.8%
Retained previous estimate 8 countries 848,000 30.5%
Expert assessment 14 countries 862,049 31.0%
https://doi.org/10.1371/journal.pntd.0007835.t002
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Fig 2. Distribution of analysis methodology.
https://doi.org/10.1371/journal.pntd.0007835.g002
Fig 3. Number of districts contributing data to the overall estimate, by year of survey.
https://doi.org/10.1371/journal.pntd.0007835.g003
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need to have their TT appropriately managed. From available data, it is estimated that 56% of
people with trichiasis have bilateral trichiasis.
While our calculations lessen the uncertainty around the global backlog estimate, important
limitations remain. Expert assessment of available data was used for 14 endemic countries, in
eight of which the estimate was zero cases. The sensitivity analysis performed on these eight
countries suggests that the zero estimates could contribute to global underestimation by a mar-
gin of 13,285. Ethiopia, Mali, and Niger have undergone intensive surgical scale-up in the time
since the most recent round of prevalence surveys. Because of this programmatic output, and a
lack of consensus around how to counterbalance backlog reduction with new incident cases
and post-surgical recurrence (both of which are inescapable, but presently difficult to accu-
rately quantify) these countries provided results based on expert assessment—albeit assess-
ments grounded on 196 (Ethiopia), 55 (Mali) and 49 (Niger) PBPS datasets, and
corresponding district-level data on surgical output. Uncertainty is greatest among the eight
countries in which previous estimates were retained; these countries accounted for 848 thou-
sand cases of trichiasis (31% of the global estimate) and further investigation is needed here.
India, which accounts for 443,000 cases of trichiasis (52% of the total retained estimate) is a
particular priority. A second ongoing uncertainty stems from the unavailability of raw data for
398 districts, for which, as a result, age- and sex- stratification was not possible. As noted in
our calculations, there is a mean prevalence reduction against the raw prevalence estimate of
×0�45, which was applied to previously-unstratified district-level estimates. Third, our CIs
reflect statistical uncertainty. Because statistical uncertainty is uncorrelated across countries,
our method of aggregating CIs across administrative boundaries overestimates statistical
uncertainty at regional and global levels. However, there are other sources of uncertainty in
addition to statistical uncertainty, so it is not possible to say whether our regional and global
CIs are biased. Fourth, we have implicitly assumed the prevalence of TT in those aged<15
years to be negligible. This is generally valid, but was a necessary assumption because of the
unavailability of data on paediatric trichiasis in many pre-GTMP surveys. Fifth, it is possible
Table 3. Estimated region-level trichiasis backlogs, 2016, with comparisons to the corresponding estimates for 2009.
WHO Region 2009
Estimate
2016 Estimate Ratio (2016 estimate /
2009 estimate)
Retained previous estimate or
expert assessment
(95% CI)
Not post-stratified
(reduced by a factor
of 0�45)
(95% CI)
Post-stratified
(95% CI)
Total
(95% CI)
African Region 3,846,500 915,274
(241,969–1,855,593)
247,570
(150,310–363,186)
547,151
(283,052–
913,841)
1,709,995
(675,331–
3,132,620)
0.45
Region of the Americas 58,050 58,000
(15,401–117,488)
566
(272–863)
48
(0–123)
58,614
(15,673–118475)
1.01
Eastern Mediterranean
Region
660,000 126,875
(33,690–257,006)
66,171
(45,441–86,702)
106,003
(39,337–
196,230)
299,049
(118,467–
539,937)
0.52
South-East Asia Region 485,000 443,000
(117,632–897,368)
25,240
(16,889–33,631)
3,252
(462–7,323)
471,492
(134,982–
938,323)
0.97
Western Pacific Region 2,630,000 166,900
(44,318–338,083)
71,288
(70,399–72,184)
5,947
(810–13,027)
244,135
(115,527–
423,294)
0.09
Total 8,248,050 1,710,049
(453,010–3,465,538)
410,835
(283,311–556,567)
662,403
(323,661–
1,130,543)
2,783,285
(1,059,980–
5,152,649)
0.35
https://doi.org/10.1371/journal.pntd.0007835.t003
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that there are some population-based data on trichiasis of which we are unaware, but the part-
nerships engendered within the WHO Alliance for GET2020 [48]and the existence of the Tra-
choma Atlas (www.trachomaatlas.org) seem to us to make it unlikely that there are many
estimates in this category. Finally, some of the surveys contributing data were conducted more
than a decade ago (Fig 2). Although we note above that reductions in active trachoma preva-
lence are likely to have reduced the incidence of TT over time, we cannot adjust for such
reductions within our data. Similarly, we are unable to adjust for the effects of all-cause mortal-
ity in patients with TT, population ageing, and other broad demographic changes that have
occurred since raw data were collected.
Ongoing lack of trichiasis (and TF) prevalence data for 235 suspected-endemic districts is
due to local insecurity, and the global trachoma community stands ready to support national
governments to undertake the needed mapping in those populations, when and if security con-
ditions improve to allow safe conduct of fieldwork.
It is recognized[11] that the PBPS methodology described earlier is potentially imprecise in
estimating TT against the WHO elimination target of�0.2% in adults. Thus, at district level,
the uncertainty around the estimates of the TT backlog can be large. This is reflected in our
CIs. Work is underway to try to develop more reliable methodologies for estimating the preva-
lence of trichiasis.
At present, the diagnosis of TT is based on the presence of clinical trichiasis (one or more
lashes touching the globe or evidence of recent epilation of in-turned eyelashes) plus residence
in a (presumed) trachoma-endemic setting. This definition is by nature somewhat circular and
may need review, as it inevitably leads to classification of trichiasis as TT regardless of whether
trachomatous conjunctival scarring is present or not. Trichiasis without trachomatous con-
junctival scarring may be age-related or due to trauma, distichiasis, epiblepharon or other
inflammatory disease[49]; the sight-threatening potential and optimal management strategies
for non-trachomatous trichiasis still require further investigation[50].
Assumptions were made when adjusting the data for age and sex. First, we assumed that
ages reported in surveys were accurate. However, it is reasonable to hypothesise that during a
survey, individuals demonstrate a terminal digit preference when stating their age. Second,
this analysis assumed that UNdata population pyramids used were representative of all dis-
tricts for which survey data were available. Finally, as already noted, we assumed zero trichiasis
cases in the population aged 14 years and younger; studies demonstrate a high correlation
between trichiasis and increased age[51–54].
These calculations of national and global TT burdens are point-prevalence estimates based
on data of differing vintages; they will change as additional surveys, baseline or impact, are
undertaken. Other than for Ethiopia, Mali and Niger, the estimates do not take into account
the number of surgeries done during the period between the most recent survey and the cut-
off date for this analysis. Nevertheless, estimates of current national TT backlog are essential
for countries to appropriately allocate resources for surgical campaigns. Future district-level
impact surveys in countries with trachoma elimination programs will provide progressively
improved evidence for countries to assess their residual TT burden and, ultimately, validate
elimination of trichiasis as a public health problem. Baseline surveys of trachoma are still
needed in a handful of countries (e.g., Egypt, Somalia and Central African Republic); these will
lead to revisions in national estimates. In some settings, there will be a need to undertake tri-
chiasis-only surveys [55] in order to assess progress to elimination. Unfortunately, insecurity
may continue to limit surveys in a few, but not all, of the settings in which previous estimates
were retained. Where possible, surveys should be undertaken. Lack of primary data will ham-
per progress to the declaration of global elimination of trachoma as a public health problem.
As new primary survey findings become available it will be possible to update global figures.
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Modelling may also be an important tool for addressing this challenge. Continued efforts by
national health ministries, WHO, program partners and researchers to carry out baseline,
impact, and pre-surveillance surveys drive revisions to the global elimination of trachomatous
trichiasis as a public health problem.
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